5.74 USD
-0.06 (-1.03%)
We assign a fundamental rating of 5 out of 10 to ULBI. ULBI was compared to 91 industry peers in the Electrical Equipment industry. ULBI has an average financial health and profitability rating. ULBI may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year ULBI was profitable.
ULBI had a positive operating cash flow in the past year.
In multiple years ULBI reported negative net income over the last 5 years.
Of the past 5 years ULBI 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.77%, ULBI is in the better half of the industry, outperforming 68.13% of the companies in the same industry.
ULBI has a better Return On Equity (1.25%) than 68.13% of its industry peers.
ULBI has a Return On Invested Capital of 3.23%. This is in the better half of the industry: ULBI outperforms 65.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ULBI is significantly below the industry average of 9.90%.
The last Return On Invested Capital (3.23%) for ULBI is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.77% | ||
| ROE | 1.25% | ||
| ROIC | 3.23% |
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
1.3 Margins
ULBI has a better Profit Margin (0.92%) than 70.33% of its industry peers.
ULBI's Profit Margin has declined in the last couple of years.
The Operating Margin of ULBI (4.20%) is better than 68.13% of its industry peers.
In the last couple of years the Operating Margin of ULBI has remained more or less at the same level.
Looking at the Gross Margin, with a value of 23.89%, ULBI is in line with its industry, outperforming 49.45% of the companies in the same industry.
ULBI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | 0.92% | ||
| GM | 23.89% |
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
The number of shares outstanding for ULBI has been increased compared to 1 year ago.
Compared to 5 years ago, ULBI has more shares outstanding
Compared to 1 year ago, ULBI has a worse debt to assets ratio.
2.2 Solvency
ULBI has an Altman-Z score of 1.78. This is a bad value and indicates that ULBI is not financially healthy and even has some risk of bankruptcy.
ULBI's Altman-Z score of 1.78 is in line compared to the rest of the industry. ULBI outperforms 57.14% of its industry peers.
ULBI has a debt to FCF ratio of 5.62. This is a neutral value as ULBI would need 5.62 years to pay back of all of its debts.
ULBI's Debt to FCF ratio of 5.62 is fine compared to the rest of the industry. ULBI outperforms 71.43% of its industry peers.
ULBI has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, ULBI perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 5.62 | ||
| Altman-Z | 1.78 |
ROIC/WACC0.44
WACC7.27%
2.3 Liquidity
ULBI has a Current Ratio of 2.99. This indicates that ULBI is financially healthy and has no problem in meeting its short term obligations.
ULBI has a better Current ratio (2.99) than 75.82% of its industry peers.
ULBI has a Quick Ratio of 1.42. This is a normal value and indicates that ULBI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.42, ULBI is doing good in the industry, outperforming 60.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.99 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The earnings per share for ULBI have decreased strongly by -77.78% in the last year.
Measured over the past 5 years, ULBI shows a small growth in Earnings Per Share. The EPS has been growing by 3.31% on average per year.
The Revenue has grown by 12.94% in the past year. This is quite good.
ULBI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)-77.78%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-450%
Revenue 1Y (TTM)12.94%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.51%
3.2 Future
The Earnings Per Share is expected to grow by 43.60% on average over the next years. This is a very strong growth
Based on estimates for the next years, ULBI will show a quite strong growth in Revenue. The Revenue will grow by 18.34% on average per year.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ULBI is valuated quite expensively with a Price/Earnings ratio of 41.00.
Based on the Price/Earnings ratio, ULBI is valued a bit cheaper than 69.23% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.39. ULBI is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 6.05 indicates a rather cheap valuation of ULBI.
ULBI's Price/Forward Earnings ratio is rather cheap when compared to the industry. ULBI is cheaper than 98.90% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.84. ULBI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41 | ||
| Fwd PE | 6.05 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 92.31% of the companies listed in the same industry.
ULBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ULBI is cheaper than 95.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.68 | ||
| EV/EBITDA | 10.35 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULBI's earnings are expected to grow with 43.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)12.4
EPS Next 2Y43.6%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ULBI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:ULBI (12/19/2025, 8:19:47 PM)
5.74
-0.06 (-1.03%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners73.05%
Inst Owner Change-2.65%
Ins Owners3.19%
Ins Owner Change0.58%
Market Cap95.57M
Revenue(TTM)186.53M
Net Income(TTM)1.72M
Analysts82.86
Price Target14.28 (148.78%)
Short Float %0.8%
Short Ratio2.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.09%
Min EPS beat(2)-131.19%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-72.67%
Min EPS beat(4)-131.19%
Max EPS beat(4)-15.03%
EPS beat(8)3
Avg EPS beat(8)-15.66%
EPS beat(12)5
Avg EPS beat(12)43.11%
EPS beat(16)7
Avg EPS beat(16)38.76%
Revenue beat(2)0
Avg Revenue beat(2)-13.21%
Min Revenue beat(2)-19.77%
Max Revenue beat(2)-6.65%
Revenue beat(4)2
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-19.77%
Max Revenue beat(4)7.48%
Revenue beat(8)5
Avg Revenue beat(8)-1.68%
Revenue beat(12)7
Avg Revenue beat(12)2.25%
Revenue beat(16)10
Avg Revenue beat(16)3.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41 | ||
| Fwd PE | 6.05 | ||
| P/S | 0.51 | ||
| P/FCF | 10.68 | ||
| P/OCF | 7.62 | ||
| P/B | 0.7 | ||
| P/tB | 1.39 | ||
| EV/EBITDA | 10.35 |
EPS(TTM)0.14
EY2.44%
EPS(NY)0.95
Fwd EY16.53%
FCF(TTM)0.54
FCFY9.37%
OCF(TTM)0.75
OCFY13.13%
SpS11.2
BVpS8.24
TBVpS4.12
PEG (NY)0.6
PEG (5Y)12.4
Graham Number5.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.77% | ||
| ROE | 1.25% | ||
| ROCE | 4.15% | ||
| ROIC | 3.23% | ||
| ROICexc | 3.4% | ||
| ROICexgc | 5.52% | ||
| OM | 4.2% | ||
| PM (TTM) | 0.92% | ||
| GM | 23.89% | ||
| FCFM | 4.8% |
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 5.62 | ||
| Debt/EBITDA | 3.52 | ||
| Cap/Depr | 66.95% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 95.05% | ||
| Profit Quality | 521.01% | ||
| Current Ratio | 2.99 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 1.78 |
F-Score3
WACC7.27%
ROIC/WACC0.44
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.78%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-450%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.94%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.51%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.81%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3629.58%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y506.14%
OCF growth 3Y56.62%
OCF growth 5YN/A
ULTRALIFE CORP / ULBI FAQ
What is the ChartMill fundamental rating of ULTRALIFE CORP (ULBI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ULBI.
Can you provide the valuation status for ULTRALIFE CORP?
ChartMill assigns a valuation rating of 7 / 10 to ULTRALIFE CORP (ULBI). This can be considered as Undervalued.
Can you provide the profitability details for ULTRALIFE CORP?
ULTRALIFE CORP (ULBI) has a profitability rating of 5 / 10.
How financially healthy is ULTRALIFE CORP?
The financial health rating of ULTRALIFE CORP (ULBI) is 4 / 10.